Skip to main content
. 2014 May 29;29(11):2028–2035. doi: 10.1093/ndt/gfu190

Table 1.

Renal and metabolic effects of 3 weeks of treatment with PD173074 or vehicle in 5/6 nephrectomy (Nx) rats

  Sham (reference values) Sham + PD173074
5/6 Nx + Vehicle
5/6 Nx + PD173074
ANOVA
Pre-treatment Post-treatment Pre-treatment Post-treatment Pre-treatment Post-treatment P-value
(n = 8) (n = 4) (n = 4) (n = 8) (n = 8) (n = 7) (n = 7)
Body weight (g) 353 ± 13 196 ± 6*,***,****,***** 335 ± 21 311 ± 13 378 ± 20 292 ± 20** 356 ± 19 <0.0001
Weight gain over 3 weeks (g) 163 ± 10 140 ± 15 67 ± 11* 76 ± 27* 0.0007
Serum creatinine (mg/dL) 0.19 ± 0.02 0.18 ± 0.01 0.21 ± 0.01 0.52 ± 0.04*,**,*** 0.56 ± 0.04*,**,*** 0.46 ± 0.06*,**,*** 0.52 ± 0.05*,**,*** <0.0001
Blood urea nitrogen (mg/dL) 17 ± 0.1 14 ± 1.7 15 ± 0.7 37 ± 3.3*,**,*** 35 ± 1.6*,**,*** 41 ± 7.4*,**,*** 33 ± 3.4*,**,*** <0.0001
Creatinine clearance (mL/min/100 g) 0.99 ± 0.07 0.90 ± 0.09 0.94 ± 0.06 0.40 ± 0.03*,**,*** 0.40 ± 0.04*,**,*** 0.46 ± 0.06*,**,*** 0.45 ± 0.05*,**,*** <0.0001
Urine protein (mg/mg creatinine) 0.3 ± 0.03 0.3 ± 0.05 0.36 ± 0.02 5.8 ± 1.9 3.9 ± 1.4 5.4 ± 1.5 4.2 ± 1.6 0.0185
Systolic blood pressure (mmHg) 139 ± 2.5 137 ± 6.3 138 ± 4.1 213 ± 4.7*,**,*** 215 ± 6.4*,**,*** 203 ± 6.2*,**,*** 203 ± 5.2*,**,*** <0.0001
Serum phosphate (mg/dL) 6.9 ± 0.3 6.4 ± 0.2 7.1 ± 0.6 6.1 ± 0.5 6.0 ± 0.3 5.9 ± 0.6 5.7 ± 0.5 0.3297
Serum FGF23 (pg/mL) 194 (179–225) 190 (171–208) 292 (230–351) 947 (676–1159)*,**,*** 1315 (345–1900)*,**,*** 548 (402–1111)*,**,*** 865 (649–1434)*,**,*** <0.0001
PTH (pg/mL) 73 ± 18 nd nd 177 ± 26 118 ± 40 127 ± 29 60 ± 39 0.0848
1,25(OH)2D 143 ± 9 nd nd 144 ± 10 125 ± 11 144 ± 9 131 ± 8 0.4932

Results are mean ± SEM or median (25–75th percentiles). Reference values: data from sham rats after 3 weeks of treatment with vehicle. Sham animals receiving NaCl pre-treatment: 2 weeks after 5/6 nephrectomy surgery; post-treatment: after 3 weeks of treatment with vehicle or PD173074; weight gain: difference (in g) between weight from pre- to post-treatment; FGF, fibroblast growth factor; PTH, parathyroid hormone; 1,25(OH)2D, 1,25-dihydroxyvitamin D. nd, not determined.

*P < 0.001 in comparison with Sham.

**P < 0.05 in comparison with Sham + PD173074 pre-treatment.

***P < 0.05 in comparison with Sham + PD173074 post-treatment.

****P < 0.05 in comparison with 5/6 Nx + vehicle post-treatment.

*****P < 0.05 in comparison to 5/6 Nx + PD173074 post-treatment.